白内障超声乳化人工晶状体植入联合硅油取出术临床疗效观察

目的 探讨玻璃体切割术后硅油充填眼行白内障超声乳化人工晶状体植入联合硅油取出术的临床疗效。方法 2010年8月—2011年6月对35例(36眼)玻璃体切割术后硅油充填眼白内障患者行白内障超声乳化人工晶状体植入联合硅油取出术，观察患者术后1个月最佳矫正视力以及术后并发症发生情况。结果 术后1个月，3眼（8.33%）最佳矫正视力<0.01，5眼（13.89%）为0.01～0.04，10眼（27.78%）为0.05～0.09，15眼（41.67%）为0.1～0.25，3眼（8.33%）≥0.3。所有患者均无持续性角膜内皮失代偿、硅油泡残留、人工晶状体移位和玻璃体出血等并发症发生。结论 玻璃体切割术后硅油充填眼行白内障超声乳化人工晶状体植入联合硅油取出术安全、有效。

Therapeutic effect of silicone oil removal combined with phacoemulsification and intraocular lens implantation

Objective To investigate the therapeutic effect of silicone oil removal combined with phacoemulsification and intraocular lens implantation in eyes with silicone oil tamponade after vitrectomy. Methods Thirty-five patients (36 eyes) with cataract and silicone oil tamponade after vitrectomy underwent silicone oil removal combined with phacoemulsification and intraocular lens implantation between August 2010 and June 2011, the best corrected visual acuity one month after operation was observed, and the incidences of postoperative complications were recorded. Results One month after operation, the best corrected visual acuity was <0.01 in 3 eyes (8.33%), 0.01-0.04 in 5 eyes (13.89%), 0.05-0.09 in 10 eyes (27.78%), 0.1-0.25 in 15 eyes (41.67%) and ≥0.3 in 3 eyes (8.33%). There was no incidence of complications such as persisting corneal endothelial decompensation, residual silicone oil, lens dislocation and vitreous hemorrhage after operation in all patients. Conclusion Silicone oil removal combined with phacoemulsification and intraocular lens implantation is a safe and effective approach for eyes with silicone oil tamponade after vitrectomy.